194 related articles for article (PubMed ID: 37894436)
1. Image-Based Modeling of Drug Delivery during Intraperitoneal Chemotherapy in a Heterogeneous Tumor Nodule.
Rezaeian M; Heidari H; Raahemifar K; Soltani M
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894436
[TBL] [Abstract][Full Text] [Related]
2. Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy.
Shamsi M; Sedaghatkish A; Dejam M; Saghafian M; Mohammadi M; Sanati-Nezhad A
Drug Deliv; 2018 Nov; 25(1):846-861. PubMed ID: 29589479
[TBL] [Abstract][Full Text] [Related]
3. Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor - Computational approach.
Moradi Kashkooli F; Soltani M; Rezaeian M; Taatizadeh E; Hamedi MH
Microvasc Res; 2019 May; 123():111-124. PubMed ID: 30711547
[TBL] [Abstract][Full Text] [Related]
4. Mathematical Modeling of Targeted Drug Delivery Using Magnetic Nanoparticles during Intraperitoneal Chemotherapy.
Rezaeian M; Soltani M; Naseri Karimvand A; Raahemifar K
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214055
[TBL] [Abstract][Full Text] [Related]
5. Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule.
Steuperaert M; Falvo D'Urso Labate G; Debbaut C; De Wever O; Vanhove C; Ceelen W; Segers P
Drug Deliv; 2017 Nov; 24(1):491-501. PubMed ID: 28181817
[TBL] [Abstract][Full Text] [Related]
6. Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy.
Rezaeian M; Sedaghatkish A; Soltani M
Drug Deliv; 2019 Dec; 26(1):898-917. PubMed ID: 31526065
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery to solid tumors with heterogeneous microvascular networks: Novel insights from image-based numerical modeling.
Moradi Kashkooli F; Soltani M; Hamedi MH
Eur J Pharm Sci; 2020 Aug; 151():105399. PubMed ID: 32485347
[TBL] [Abstract][Full Text] [Related]
8. A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy.
Steuperaert M; Debbaut C; Carlier C; De Wever O; Descamps B; Vanhove C; Ceelen W; Segers P
Drug Deliv; 2019 Dec; 26(1):404-415. PubMed ID: 30929523
[TBL] [Abstract][Full Text] [Related]
9. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis.
Xu S; Fan H; Yin L; Zhang J; Dong A; Deng L; Tang H
Eur J Pharm Biopharm; 2016 Jul; 104():251-9. PubMed ID: 27185379
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model.
Gremonprez F; Descamps B; Izmer A; Vanhove C; Vanhaecke F; De Wever O; Ceelen W
Oncotarget; 2015 Oct; 6(30):29889-900. PubMed ID: 26375674
[TBL] [Abstract][Full Text] [Related]
11. Simulating drug penetration during hyperthermic intraperitoneal chemotherapy.
Löke DR; Helderman RFCPA; Franken NAP; Oei AL; Tanis PJ; Crezee J; Kok HP
Drug Deliv; 2021 Dec; 28(1):145-161. PubMed ID: 33427507
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion.
Ceelen W; Braet H; van Ramshorst G; Willaert W; Remaut K
Expert Opin Drug Deliv; 2020 Apr; 17(4):511-522. PubMed ID: 32142389
[No Abstract] [Full Text] [Related]
13. Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis.
Shariati M; Willaert W; Ceelen W; De Smedt SC; Remaut K
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261685
[TBL] [Abstract][Full Text] [Related]
14. The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis.
Kim J; Shim MK; Cho YJ; Jeon S; Moon Y; Choi J; Kim J; Lee J; Lee JW; Kim K
Biomaterials; 2021 Dec; 279():121189. PubMed ID: 34695659
[TBL] [Abstract][Full Text] [Related]
15. Rotational intraperitoneal pressurized aerosol chemotherapy in a porcine model.
Mun J; Park SJ; Kim HS
Gland Surg; 2021 Mar; 10(3):1271-1275. PubMed ID: 33842275
[TBL] [Abstract][Full Text] [Related]
16. PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model.
Davigo A; Passot G; Vassal O; Bost M; Tavernier C; Decullier E; Bakrin N; Alyami M; Bonnet JM; Louzier V; Paquet C; Allaouchiche B; Glehen O; Kepenekian V
Int J Hyperthermia; 2020; 37(1):144-150. PubMed ID: 32003300
[No Abstract] [Full Text] [Related]
17. Drug delivery systems for intraperitoneal therapy.
Bajaj G; Yeo Y
Pharm Res; 2010 May; 27(5):735-8. PubMed ID: 20198409
[TBL] [Abstract][Full Text] [Related]
18. The effect of electrostatic high pressure nebulization on the stability, activity and ex vivo distribution of ionic self-assembled nanomedicines.
Braet H; Andretto V; Mariën R; Yücesan B; van der Vegte S; Haegebaert R; Lollo G; De Smedt SC; Remaut K
Acta Biomater; 2023 Oct; 170():318-329. PubMed ID: 37598790
[TBL] [Abstract][Full Text] [Related]
19. Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: a narrative review.
Oh S; Paik H; Park SJ; Lee EJ; Kim HS
Gland Surg; 2021 Mar; 10(3):1244-1251. PubMed ID: 33842271
[TBL] [Abstract][Full Text] [Related]
20. Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model.
Khosrawipour V; Khosrawipour T; Kern AJ; Osma A; Kabakci B; Diaz-Carballo D; Förster E; Zieren J; Fakhrian K
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2275-80. PubMed ID: 27590613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
